Stocks · Healthcare · Medical - Instruments & Supplies
The Cooper Companies, Inc. COO
$56.77 -0.25% Close, Oct 5, 2026 · NASDAQ · Market cap $11.10B
Inexpensive vs sector
Next earnings report: Dec 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 11 quarters (average surprise over the last four: +5.8%).
- Diluted EPS over the last four quarters was $2.93, up 44.3% year over year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 39%
- EPS growth (TTM, YoY)Top 30%
- FCF growth (TTM, YoY)Top 23%
- Revenue growth, 3-year CAGRBottom 42%
- Revenue growth accelerationBottom 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 25%
- Gross marginBottom 49%
- Operating marginTop 21%
- Cash conversion (OCF / net income)Top 37%
- Accruals (lower is better)Bottom 32%
- Net debt / EBITDA (lower is better)Bottom 34%
- Interest coverTop 24%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 9%
- Free-cash-flow yieldTop 14%
- EBITDA / enterprise valueTop 17%
- Sales / enterprise valueTop 41%
- P/E vs own 5-year history (lower is better)Top 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 37%
- 6-month returnBottom 24%
- 1-year return vs S&P 500Bottom 30%
- Distance from 52-week highBottom 43%
- Trend checklist (0–4)Bottom 36%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 45%
- Consecutive EPS beatsTop 5%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetBottom 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 26%
- Maximum drawdown, 3 yearsTop 25%
- Beta vs S&P 500 (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Bottom 34%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.1% | 4.7% | ↓ |
| EPS growth (YoY) | -42.7% | 44.3% | ↑ |
| Gross margin | 67.0% | 63.6% | ↓ |
| Operating margin | 18.3% | 12.9% | ↓ |
| FCF margin | 10.2% | 16.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.7% | 6.1% | ↓ | Bottom 39% |
| EPS growth (TTM, YoY) | 44.3% | -42.7% | ↑ | Top 30% |
| Gross margin | 63.6% | 67.0% | ↓ | Bottom 49% |
| Operating margin | 12.9% | 18.3% | ↓ | Top 21% |
| Net margin | 13.5% | 10.1% | ↑ | — |
| Free-cash-flow margin | 16.0% | 10.2% | ↑ | — |
| Return on invested capital | 4.8% | — | Top 25% | |
| Revenue growth, 3-year CAGR | 7.3% | — | Bottom 42% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.81×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.63×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 5.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.54%
- Shareholder yield
- 0.54%
- Share count change, 1 year
- -3.6%
- Share count change, 3-year CAGR
- -1.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 31, 2026 (filed Sep 9, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 11
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +5.8%
- Average 2-day reaction, last 8
- -0.7%
- Positive 20 days after report
- 2 of 7
Analysts
- Consensus price target
- $65.75
- Target vs current price
- +15.8%
- Analysts with a rating
- 28
- Share rating Buy or Strong Buy
- 50%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 9, 2026 | +2.7% | -6.2% | -21.3% | — | — |
| Jun 4, 2026 | +10.0% | +2.8% | +12.2% | +23.0% | +17.9% |
| Mar 5, 2026 | +6.8% | -2.2% | -10.0% | -12.9% | -25.3% |
| Dec 4, 2025 | +3.6% | +1.4% | +6.3% | +6.8% | +9.7% |
| Aug 27, 2025 | +2.8% | +0.6% | -8.9% | -7.2% | -2.0% |
| May 29, 2025 | +3.4% | -0.2% | -15.9% | -13.0% | -6.1% |
| Mar 6, 2025 | +0.7% | -0.4% | -13.4% | -11.1% | -25.2% |
| Dec 5, 2024 | +4.0% | -1.7% | -5.4% | -12.6% | -13.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 9, 2026 | $1.15 | $1.12 | +2.7% | $1.07B |
| Jun 4, 2026 | $1.21 | $1.10 | +10.0% | $1.08B |
| Mar 5, 2026 | $1.10 | $1.03 | +6.8% | $1.02B |
| Dec 4, 2025 | $1.15 | $1.11 | +3.6% | $1.07B |
| Aug 27, 2025 | $1.10 | $1.07 | +2.8% | $1.06B |
| May 29, 2025 | $0.96 | $0.93 | +3.4% | $1.00B |
| Mar 6, 2025 | $0.92 | $0.91 | +0.7% | $964.7M |
| Dec 5, 2024 | $1.04 | $1.00 | +4.0% | $1.02B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 19.4× | 33.1× | 33th | Top 9% |
| P/E (forward) | 12.5× | — | — | — |
| EV / EBITDA | 14.8× | — | — | Top 17% |
| EV / Sales | 3.18× | — | — | Top 41% |
| Free-cash-flow yield | 6.11% | — | — | Top 14% |
| Earnings yield | 5.16% | — | — | Top 9% |
P/E over the past five years
Range 1.7× – 70.0× since Jul 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -17.9%
- Earnings per share growth (TTM)
- +44.3%
- Change in P/E multiple
- -31.9%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.2%
- 200-day average slope (20 days)
- -2.9%
- Distance from 50-day average
- -14.9%
- Distance from 200-day average
- -20.3%
- RSI (14)
- 37.3
- Relative volume
- 0.62×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 43.3%
- Volatility vs own 5-year history
- 97th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.62
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -32.7%
- Maximum drawdown, 3 years
- -52.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2021 | Sep 15, 2026 | -53.3% | 1261 days | Not yet recovered |
| Oct 12, 2020 | Oct 30, 2020 | -11.5% | 14 days | 42 days (Dec 31, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $11.10B
- P/E (TTM)
- 19.4
- EPS, diluted (TTM)
- $2.93
- Revenue (TTM)
- $4.24B
- 52-week range
- $51.01 – $89.83
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.92B | $3.31B | $3.59B | $3.90B | $4.09B |
| Gross profit | $1.96B | $2.14B | $2.36B | $2.60B | $2.48B |
| Operating income | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M |
| Net income | $2.94B | $385.8M | $294.2M | $392.3M | $374.9M |
| EPS (diluted) | $14.79 | $1.94 | $1.48 | $1.96 | $1.87 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $964.7M | $1.00B | $1.06B | $1.07B | $1.02B | $1.08B | $1.07B |
| Net income | $117.5M | $104.3M | $87.7M | $98.3M | $84.6M | $130.8M | -$77.9M | $432.8M |
| EPS (diluted) | $0.58 | $0.52 | $0.44 | $0.49 | $0.43 | $0.66 | -$0.40 | $2.24 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $738.6M | $692.4M | $607.5M | $709.3M | $796.1M |
| Capital expenditure | -$214.4M | -$242.0M | -$392.5M | -$421.2M | -$362.4M |
| Free cash flow | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| Dividends paid | -$3.0M | -$3.0M | -$3.0M | $0 | $0 |
| Net share buybacks | $1.5M | -$62.4M | $23.0M | $63.9M | -$274.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $154.7M
- Total assets
- $12.67B
- Total liabilities
- $4.34B
- Total debt
- $2.54B
- Net debt
- $2.39B
- Shareholders’ equity
- $8.33B
As of Jul 31, 2026 (filed Sep 9, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Jul 26, 2023 | $0.03 | Aug 11, 2023 |
| Jan 20, 2023 | $0.03 | Feb 10, 2023 |
| Jul 26, 2022 | $0.03 | Aug 11, 2022 |
| Jan 20, 2022 | $0.03 | Feb 9, 2022 |
| Jul 26, 2021 | $0.03 | Aug 11, 2021 |
| Jan 21, 2021 | $0.03 | Feb 9, 2021 |
| Jul 22, 2020 | $0.03 | Aug 7, 2020 |
| Jan 22, 2020 | $0.03 | Feb 10, 2020 |
Short interest
- Shares sold short
- 10,008,627
- Days to cover
- 1.89
- Change vs previous report
- +14.0%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Feb 20, 2024
- 4-for-1
- Nov 25, 2002
- 2-for-1
- Sep 22, 1995
- 1-for-3
- Sep 26, 1983
- 11-for-10